|
|
CALL
|
$504 Million
|
458
|
Q3 2025
New holding
|
|
Intellia Therapeutics Inc
|
CALL
|
$354 Million
|
1.08K
|
Q3 2025
New holding
|
|
|
|
CALL
|
$339 Million
|
1.07K
|
Q3 2025
Reduced 5.08%
|
|
Praxis Precision Medicines I
|
PUT
|
$319 Million
|
230
|
Q3 2025
New holding
|
|
|
|
|
|
CALL
|
$285 Million
|
928
|
Q3 2025
New holding
|
|
Agios Pharmaceuticals Inc
|
CALL
|
$291 Million
|
546
|
Q3 2025
Added 72.78%
|
|
|
|
CALL
|
$297 Million
|
230
|
Q3 2025
New holding
|
|
|
|
CALL
|
$242 Million
|
2.32K
|
Q3 2025
Added 33.08%
|
|
|
|
CALL
|
$236 Million
|
302
|
Q3 2025
Reduced 0.33%
|
|
|
|
CALL
|
$220 Million
|
462
|
Q3 2025
New holding
|
|
Ultragenyx Pharmaceutical In
|
PUT
|
$215 Million
|
320
|
Q3 2025
Reduced 98.86%
|
|
|
|
CALL
|
$203 Million
|
1.93K
|
Q1 2025
New holding
|
|
|
|
CALL
|
$192 Million
|
258
|
Q1 2025
New holding
|
|
|
|
CALL
|
$188 Million
|
157
|
Q3 2025
Reduced 61.04%
|
|
|
|
CALL
|
$171 Million
|
1.19K
|
Q3 2025
New holding
|
|
Mereo Biopharma Group PLC
|
CALL
|
$169 Million
|
3.5K
|
Q3 2025
New holding
|
|
|
|
|
|
CALL
|
$171 Million
|
451
|
Q3 2025
Added 7.89%
|
|
Terns Pharmaceuticals Inc
|
CALL
|
$174 Million
|
520
|
Q3 2025
Added 39.41%
|
|
|
|
CALL
|
$164 Million
|
313
|
Q1 2025
New holding
|
|
Ionis Pharmaceuticals Inc
|
CALL
|
$165 Million
|
229
|
Q3 2025
New holding
|
|
|
|
PUT
|
$159 Million
|
229
|
Q3 2025
New holding
|
|
|
|
PUT
|
$147 Million
|
688
|
Q3 2025
New holding
|
|
Harmony Biosciences Hldgs In
|
PUT
|
$143 Million
|
115
|
Q3 2025
New holding
|
|
|
|
CALL
|
$133 Million
|
460
|
Q3 2025
Added 2775.0%
|
|
Olema Pharmaceuticals Inc
|
CALL
|
$116 Million
|
209
|
Q3 2025
New holding
|
|
|
|
CALL
|
$115 Million
|
2.39K
|
Q3 2025
Added 99.92%
|
|
|
|
PUT
|
$108 Million
|
230
|
Q3 2025
Reduced 99.49%
|
|
|
|
CALL
|
$102 Million
|
151
|
Q3 2025
New holding
|
|
|
|
CALL
|
$80.8 Million
|
688
|
Q3 2025
New holding
|
|
|
|
CALL
|
$89.2 Million
|
229
|
Q3 2025
Added 99.13%
|
|
|
|
CALL
|
$68.5 Million
|
64
|
Q3 2025
New holding
|
|
|
|
CALL
|
$71.8 Million
|
230
|
Q3 2025
New holding
|
|
Capricor Therapeutics Inc
|
CALL
|
$72.6 Million
|
689
|
Q3 2025
New holding
|
|
|
|
CALL
|
$52.9 Million
|
915
|
Q3 2025
Added 201.98%
|
|
Ultragenyx Pharmaceutical In
|
CALL
|
$59.5 Million
|
347
|
Q3 2025
Reduced 30.6%
|
|
|
|
CALL
|
$42.4 Million
|
229
|
Q3 2025
New holding
|
|
Anavex Life Sciences Corp
|
CALL
|
$49.7 Million
|
322
|
Q3 2025
New holding
|
|
Circle Internet Group Inc
|
PUT
|
$48.8 Million
|
68
|
Q3 2025
New holding
|
|
|
|
PUT
|
$42.1 Million
|
229
|
Q3 2025
New holding
|
|
|
|
CALL
|
$48.1 Million
|
412
|
Q3 2025
New holding
|
|
|
|
CALL
|
$38.1 Million
|
175
|
Q2 2025
Added 191.67%
|
|
Arcturus Therapeutics Hldgs
|
PUT
|
$38.6 Million
|
345
|
Q3 2025
New holding
|
|
|
|
CALL
|
$44.9 Million
|
115
|
Q3 2025
New holding
|
|
Recursion Pharmaceuticals In
|
CALL
|
$37.7 Million
|
1.61K
|
Q1 2025
New holding
|
|
|
|
CALL
|
$49.4 Million
|
152
|
Q3 2025
New holding
|
|
|
|
CALL
|
$25.3 Million
|
675
|
Q3 2025
New holding
|
|
|
|
CALL
|
$25.1 Million
|
10
|
Q3 2025
New holding
|
|
|
|
CALL
|
$34.4 Million
|
42
|
Q3 2025
New holding
|
|
|
|
PUT
|
$36.3 Million
|
691
|
Q3 2025
New holding
|
|
|
|
PUT
|
$31.3 Million
|
176
|
Q3 2025
Reduced 99.73%
|
|
